337 related articles for article (PubMed ID: 23800367)
1. Peripheral regulatory cells immunophenotyping in primary Sjögren's syndrome: a cross-sectional study.
Furuzawa-Carballeda J; Hernández-Molina G; Lima G; Rivera-Vicencio Y; Férez-Blando K; Llorente L
Arthritis Res Ther; 2013; 15(3):R68. PubMed ID: 23800367
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.
Furuzawa-Carballeda J; Bostock IC; Lima G; Mancilla-Urrea E; Mondragón G; Reyes-Acevedo R; Chevaile A; Morales-Buenrostro LE; Llorente L; Alberú J
Transpl Immunol; 2014 Mar; 30(2-3):107-13. PubMed ID: 24561014
[TBL] [Abstract][Full Text] [Related]
3. The correlation of CD19 + CD24 + CD38 + B cells and other clinicopathological variables with the proportion of circulating Tregs in breast cancer patients.
Gheybi MK; Farrokhi S; Ravanbod MR; Ostovar A; Mehrzad V; Nematollahi P
Breast Cancer; 2017 Nov; 24(6):756-764. PubMed ID: 28429331
[TBL] [Abstract][Full Text] [Related]
4. Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study.
Furuzawa-Carballeda J; Lima G; Simancas P; Ramos-Bello D; Simancas M; Bostock IC; Vilatobá M; Gabilondo B; Granados J; Morales-Buenrostro L; Alberú J; Llorente L
J Transplant; 2012; 2012():256960. PubMed ID: 23213488
[TBL] [Abstract][Full Text] [Related]
5. B cell subsets and dysfunction of regulatory B cells in IgG4-related diseases and primary Sjögren's syndrome: the similarities and differences.
Lin W; Jin L; Chen H; Wu Q; Fei Y; Zheng W; Wang Q; Li P; Li Y; Zhang W; Zhao Y; Zeng X; Zhang F
Arthritis Res Ther; 2014 May; 16(3):R118. PubMed ID: 24887143
[TBL] [Abstract][Full Text] [Related]
6. Increased IL-21 Expression Induces Granzyme B in Peripheral CD5(+) B Cells as a Potential Counter-Regulatory Effect in Primary Sjögren's Syndrome.
Papp G; Gyimesi E; Szabó K; Zöld É; Zeher M
Mediators Inflamm; 2016; 2016():4328372. PubMed ID: 26884645
[TBL] [Abstract][Full Text] [Related]
7. CD19
Chen Q; Lai L; Chi X; Lu X; Wu H; Sun J; Wu W; Cai L; Zeng X; Wang C; Chen W; Peng A
Mediators Inflamm; 2020; 2020():3019378. PubMed ID: 32104147
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-35 promotes Breg expansion and interleukin-10 production in CD19
Zhang Y; Wei S; Wu Q; Shen X; Dai W; Zhang Z; Chen M; Huang H; Ma L
Clin Rheumatol; 2022 Aug; 41(8):2403-2416. PubMed ID: 35420296
[TBL] [Abstract][Full Text] [Related]
9. Elevated level of circulating CD4
Liu C; Guan Z; Zhao L; Song Y; Wang H
Mod Rheumatol; 2017 Jul; 27(4):630-637. PubMed ID: 27538522
[TBL] [Abstract][Full Text] [Related]
10. Comparison of peripheral blood B cell subset ratios and B cell-related cytokine levels between ocular and generalized myasthenia gravis.
Hu Y; Wang J; Rao J; Xu X; Cheng Y; Yan L; Wu Y; Wu N; Wu X
Int Immunopharmacol; 2020 Mar; 80():106130. PubMed ID: 31978800
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.
Furuzawa-Carballeda J; Fonseca-Camarillo G; Lima G; Yamamoto-Furusho JK
Clin Dev Immunol; 2013; 2013():278035. PubMed ID: 24282429
[TBL] [Abstract][Full Text] [Related]
12. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation.
Flores-Borja F; Bosma A; Ng D; Reddy V; Ehrenstein MR; Isenberg DA; Mauri C
Sci Transl Med; 2013 Feb; 5(173):173ra23. PubMed ID: 23427243
[TBL] [Abstract][Full Text] [Related]
13. Purification and Immunophenotypic Characterization of Human CD19
Bradford HF; Mauri C
Methods Mol Biol; 2021; 2270():77-90. PubMed ID: 33479894
[TBL] [Abstract][Full Text] [Related]
14. IL-10-producing regulatory B-cells suppressed effector T-cells but enhanced regulatory T-cells in chronic HBV infection.
Liu Y; Cheng LS; Wu SD; Wang SQ; Li L; She WM; Li J; Wang JY; Jiang W
Clin Sci (Lond); 2016 Jun; 130(11):907-19. PubMed ID: 26980345
[TBL] [Abstract][Full Text] [Related]
15. Differential cytokine expression and regulatory cells in patients with primary and secondary Sjögren's syndrome.
Furuzawa-Carballeda J; Sánchez-Guerrero J; Betanzos JL; Enriquez AB; Avila-Casado C; Llorente L; Hernández-Molina G
Scand J Immunol; 2014 Dec; 80(6):432-40. PubMed ID: 25346207
[TBL] [Abstract][Full Text] [Related]
16. Reduced CD5(+) CD24(hi) CD38(hi) and interleukin-10(+) regulatory B cells in active anti-neutrophil cytoplasmic autoantibody-associated vasculitis permit increased circulating autoantibodies.
Aybar LT; McGregor JG; Hogan SL; Hu Y; Mendoza CE; Brant EJ; Poulton CJ; Henderson CD; Falk RJ; Bunch DO
Clin Exp Immunol; 2015 May; 180(2):178-88. PubMed ID: 25376552
[TBL] [Abstract][Full Text] [Related]
17. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
[TBL] [Abstract][Full Text] [Related]
18. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren's syndrome.
Lin X; Wang X; Xiao F; Ma K; Liu L; Wang X; Xu D; Wang F; Shi X; Liu D; Zhao Y; Lu L
Cell Mol Immunol; 2019 Dec; 16(12):921-931. PubMed ID: 30948793
[TBL] [Abstract][Full Text] [Related]
19. Defective CD19+CD24
Cencioni MT; Ali R; Nicholas R; Muraro PA
Mult Scler; 2021 Jul; 27(8):1187-1197. PubMed ID: 32924828
[TBL] [Abstract][Full Text] [Related]
20. Effect of CD40/CD40L signaling on IL-10-producing regulatory B cells in Chinese children with Henoch-Schönlein purpura nephritis.
Yang B; Tan X; Xiong X; Wu D; Zhang G; Wang M; Dong S; Liu W; Yang H; Li Q
Immunol Res; 2017 Jun; 65(3):592-604. PubMed ID: 27837410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
